Skip to content
OpenCapital
Get started

PROCEPT BioRobotics Corporation PRCT U.S. — Revenue

Similar metrics at other companies

Axogen logo
AXGNU.S. — Revenue
$60.13M+25.7%
Inspire Medical Systems logo
INSPUnited States — Revenue
$195.6M+1.0%
10x Genomics, Inc. logo
TXGUnited States — Revenue
$76.69M-11.7%
MSA
MSAUnited States — Revenue
$235.84M-1.2%
Navan, Inc. logo
NAVNUnited States — Revenue
$144.71M+51.0%
Distribution Solutions Group, Inc. logo
DSGRUnited States — Revenue
$366.24M+2.5%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-24.8%
Enterprise value$1.25B—
P/S3.7×—

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's u.s. — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's U.S. — revenue?
PROCEPT BioRobotics Corporation (PRCT) reported U.S. — revenue of $72.02M in Q1 2026.
How has PROCEPT BioRobotics Corporation's U.S. — revenue changed year-over-year?
PROCEPT BioRobotics Corporation's U.S. — revenue increased by 19.4% year-over-year, from $60.29M to $72.02M.
What is the long-term trend for PROCEPT BioRobotics Corporation's U.S. — revenue?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's U.S. — revenue has grown at a 74.8% compound annual growth rate (CAGR), from $28.95M to $270.38M.
What does U.S. — revenue mean?
This metric represents the total net sales generated from products and services within the United States geographic market. It serves as a primary indicator of the company's commercial adoption and market penetration for its surgical robotic systems in this specific region. Tracking this figure helps investors assess the scale of domestic operations and the effectiveness of regional sales strategies.